SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" ($CAW) meme coin is trending as the community rallies around its organic, multichain nature and strong community, often referred to as the "caWmunity". Amidst the meme-driven chatter, discussions highlight its deflationary burn mechanism, potential for high growth, and comparisons with other meme coins, as well as a meme battle with $PMV.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to renewed interest in its low float and potential for a short squeeze, with some traders drawing comparisons to previous high-flying stocks. Community members are actively discussing potential price targets and monitoring key breakout levels, fueled by past AI deals. Bullish sentiment seems to be building with many anticipating a significant move, while others urge caution.

Wayfinder

Wayfinder (PROMPT CRYPTO) is trending as traders discuss its potential in the AI space, drawing comparisons to other AI-related tokens. Community members are actively watching for breakout signals and debating possible price movements, while also keeping an eye on bot activity and potential manipulation.

Amplify ETF Trust - Amplify Seymour Cannabis ETF

Amplify Seymour Cannabis ETF

The Amplify Seymour Cannabis ETF ($CNBS) is trending as the cannabis sector reacts to potential catalysts like the reintroduction of the SAFE Banking Act. Community discussions highlight the ETF's holdings and potential for growth, especially with increased access to U.S. MSOs (Multi-State Operators) through swaps. Some traders believe the sector is currently undervalued, presenting a buying opportunity.

Loopring is a Decentralized Exchange (DEX) built on an Ethereum Layer-2 (L2) solution called zkRollup. It has both Automated Market Maker (AMM)-based and orderbook-based exchanges.   zkRollup is an Ethereum L2 scaling solution that migrates computations off the blockchain. Loopring protocol only uses the underlying Ethereum blockchain as a data layer and a verification layer. As a result, Loopring's throughput is as high as 2,025 trades per second compared to Ethereum’s current throughput of 15 transactions per second. The result is that the cost per trade settlement is as small as $0.00015.  Loopring's performance is sufficient for professional traders and market makers to deploy algorithmic strategies and other automated trading bots. This was not previously possible on any DEX as it was prohibitively slow and expensive. By building on top of Loopring 3.0, orderbook-based DEXs can be commercially viable for the first time. Loopring expects non-custodial exchanges can begin to outcompete and displace many centralized counterparts.

Loopring

Loopring is trending as community members discuss potential AI-related news catalysts and possible short squeezes. Bullish sentiment is fueled by anticipation of a major price movement, with some eyeing targets significantly higher. However, there are also mentions of past disappointments and skepticism about its ability to keep pace with broader market gains.

Digimarc Corp. provides digital watermarking technology services. It develops solutions, licenses intellectual property, and provides development services. The company also connects print, audio, and packaging to brand-defined online content, protects, identifies, and tracks digital files, and confirms content and objects are genuine, unaltered, and from an authorized source. Its products include Digimarc Validate, Digimarc Engage, Digimarc Recycle and Digimarc Retail Experience. The company was founded on January 3, 1995 and is headquartered in Beaverton, OR.

Digimarc Corporation

Digimarc ($DMRC) is trending amid ongoing discussions about a major contract, potentially with Walmart ($WMT), driving speculation and optimism within the community. Despite positive sentiments and potential applications of Digimarc's technology, concerns linger around leadership, execution, and past promises, contributing to community skepticism. Investor focus remains on upcoming earnings and updates regarding strategic partnerships.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community discusses its potential, partnerships, and utility amid market fluctuations. Community members are weighing in on the long-term outlook, potential price targets, and whether the token can break away from broader market pressures. Talk includes recent developments, staking, and speculation about the Algorand Foundation's plans.

World Mobile Token (WMTX) is the utility token that powers the World Mobile network, a decentralized mobile network at the forefront of the DePIN space. World Mobile aims to connect the world by leveraging blockchain technology and a sharing economy. By becoming an AirNode operator or a token staker, anyone can earn rewards for providing telco services to customers or securing the network. The World Mobile network is disrupting the trillion-dollar telco industry and creating a more inclusive, sustainable, and privacy-respecting wireless service for everyone.

World Mobile Token

World Mobile Token ($WMTX) is trending amid discussions about its Unity node rewards program, which is now live and generating early rewards for operators. The community is also highlighting the project's multichain strategy and its potential within the Decentralized Physical Infrastructure Networks (DePIN) sector, emphasizing its real-world impact on global connectivity.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnight ($NIGHT) is trending amid community discussions about its privacy features and potential within the Cardano ecosystem, with some comparing it to $COTI. Recent price volatility and airdrop claims are also sparking conversations, alongside debates about its real-world utility and comparisons to other privacy coins like $ZEC.

ContextLogic Holdings, Inc. is seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses that are complementary to its operations. The company is headquartered in Oakland, CA.

ContextLogic Holdings Inc.

ContextLogic Inc

ContextLogic is trending as investors discuss its potential acquisition of US Salt, a move that would transform the company into a business ownership platform. Community members are weighing the implications of this acquisition, particularly regarding the company's shift in business model and the possibility of a rights offering. The focus remains on the potential for high-velocity repricing due to the micro-float and fresh fundamental catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Fundamental Report for IWM

Below is Validea's ETF fundamental report for iShares Russell 2000 ETF (IWM). The report looks at IWM's exposure to the major investing factors including value, quality, momentum and low volatility...

5 Momentum ETFs With More Room to Run in 2026

AI strength, solid earnings, and upbeat 2026 forecasts fuel momentum plays. These five ETFs -- GDXJ, SLV, KBE, MDYV & IWM -- may still have room to run.

Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank

Adding to the unusually strong performance of the Russell 2000 this year, these top performers may certainly serve as stocks to add to your watchlist

Zacks Investment Ideas feature highlights: Carvana, Lennar, Bank of America, Newmont Mining and the Russell 2000 Index ETF

A widely expected Fed rate cut puts Powell's tone in focus as investors watch how Carvana and other rate-sensitive names react.

December FOMC Preview: Rate Cut Priced in but Tone is Everything

On Wednesday, the Federal Reserve will take center stage. With a rate cut widely expected, the real story will be expectations for 2026 and how the Fed balances softening employment data with ongoing economic strength.

<ul class="summary-bullets"><li>The S&amp;P 500 is only trading within a 100-point range from its all-time highs.</li><li>Retail traders have bearish retail positioning on SPY and QQQ amid skepticism over Nvidia’s chip-export approval to China.</li><li>Siegel expects a flat December performance but sees potential for healthy consolidation and rotation into smaller, rate-sensitive stocks.</li></ul>U.S. stock futures traded narrowly mixed early Tuesday, underscoring the indecision among traders as they await the Federal Reserve’s final rate decision for the year. Risk sentiment could also take a beating from President Donald Trump’s renewed tariff salvo fired at North American neighbors, Mexico and Canada, as well as India.Writing on Truth Social, Trump&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115686410399815717">berated</a> Mexico for violating the Water Treaty and issued an ultimatum: if Mexico does not release the agreed-upon water quota, a 5% tariff will be imposed. Separately, while speaking at a White House event, the president said he was mulling fresh tariffs on agricultural products such as Indian rice and Canadian fertilizer, Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-08/trump-eyes-tariffs-over-cheap-canadian-fertilizer-indian-rice">reported.</a>Traders may also sift through a couple of economic data points and some key earnings reports as they plot their next moves.WisdomTree Senior Economist Jeremy Siegel calls for a relatively flat performance in December as the markets digest the Fed’s message and wait for clarity on tariffs and policy heading into 2026. In his weekly commentary, the economist and strategist said, “The one seasonal I do give more weight to is the short window between Christmas and New Year’s, the so-called Santa Claus rally.”The strategist said the consolidation he predicts would be healthy "if it comes with a subtle rotation — away from over-owned megacaps and toward smaller, rate-sensitive names that benefit most from the first leg of easing.”<h2 class="st-heading-2">How Futures Are Trading</h2>As of 2:40 a.m. ET on Tuesday, the Nasdaq 100 futures, S&amp;P 500, and Dow futures were marginally higher, while the Russell 2000 futures traded down 0.08%.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, remained ‘bearish’ as of early Tuesday. The message volume on the SPY and QQQ ETF streams remained at ‘normal’ and ‘high’ levels, respectively.Most observers did not view the Trump administration’s decision to allow the export of Nvidia’s H200 chips to China favorably, as they doubted China's uptake.<stembedurl>https://stocktwits.com/newsman07336/message/638555952</stembedurl>Another user stated that a Santa Claus rally, which gives the market a year-end lift, is unlikely this year.<stembedurl>https://stocktwits.com/8Inevitableoutcome/message/638552484</stembedurl><h2 class="st-heading-2">How Markets Fared Monday</h2>Stocks were in a “wait-and-watch” mode on Monday amid uncertainty surrounding the Fed decision, due Wednesday. All but the IT sector closed in the red, with communication services, consumer discretionary, material, healthcare, and utility stocks ending markedly lower. In the process, the S&amp;P 500 Index moved away from its all-time high of 6,920.34 before settling at 6,846.51.The QQQ, SPY, and&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> fell 0.19%, 0.32% and 0.39%, respectively, while the&nbsp;<a href="https://stocktwits.com/symbol/IWM">iShares Russell 2000 ETF (IWM)</a> closed marginally higher.<h2 class="st-heading-2">Key Catalysts To Watch Out For</h2>The National Federation of Independent Business (NFIB) is scheduled to release its optimism index for November at 6 a.m. ET. The index, which measures optimism among small businesses, is expected to remain unchanged at 98.2.The Bureau of Labor Statistics is set to release the results of the Job Openings and Labor Turnover (JOLTS) survey for October at 10 a.m. ET. The reading will be closely watched, as the government suspended the release of the September report due to the shutdown.Notable names reporting earnings on Tuesday are AutoZone (AZO), G-III Apparel (GIII), Sailpoint (SAIL), AeroVironment (AVAV), Casey’s General (CASY), Cracker Barrel (CBRL), and GameStop (GME).&nbsp;<h2 class="st-heading-2">How Other Markets Fared</h2>The Asian markets fell across the board as the Fed decision loomed, while Japanese stocks closed modestly higher, supported by the yen's weakness. In a major central bank decision from the region, the Reserve Bank of Australia announced a pause, in line with expectations, and hinted that further easing is unlikely.The greenback was weaker against most major currencies, except the yen. The 10-year U.S. Treasury note yield was little changed early Tuesday after rising 3.3 points to 4.172% in the previous session. Among commodities, crude oil futures fell modestly, with the WTI crude now trading below $59 level, and gold futures also eased.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/what-a-post-powell-fed-may-look-like-under-trump-favorite-kevin-hassett/cLIYqZPREm7">What A Post-Powell Federal Reserve May Look Like Under Trump Favorite Kevin Hassett</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on October 01, 2025, in New York City.  

Nasdaq, S&P 500 Futures Freeze As Fresh Trump Tariff Threats On Mexico, India Collide With Fed Jitters — Strategist Warns Santa Rally Looks Unlikely

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.

Equity

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.


Why High-Income Seekers Are Turning to Autocallable ETFs

We explain how Autocallable ETFs work and who they are for.


<ul class="summary-bullets"><li>H.C. Wainwright conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.</li><li>Capricor’s bumper rally on Wednesday helped the stock turn green for the year.</li><li>Retail sees the stock as a long-term winner following the Phase 3 results.</li></ul>Two decades after its modest beginnings and more than a decade after becoming a public company, San Diego, California-based Capricor Therapeutics made another stride toward becoming a commercial-stage company. After a failed first try, the small-cap biotech is hoping to push its experimental cell-therapy for a rare genetic muscular disorder past the finish line without any hiccups.Wall Street analysts and the investment community received the recently released late-stage trial data for the treatment candidate well. While sell-side analysts were generous with their price target hikes, signaling their excitement toward the data, investors sent the stock up by over 530% at one point in Wednesday’s session. The initial euphoria faded slightly, but didn’t die out, as<a href="https://stocktwits.com/symbol/CAPR">&nbsp;Capricor’s stock</a> had enough verve to finish the day up 371% at $29.96,&nbsp;ending at an eight-year high and marking its best day ever.<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_2_28_48_AM_png_599beb080a.webp" alt="Screenshot 2025-12-04 at 2.28.48 AM.png">Source: Koyfin<h2 class="st-heading-2">What Fueled CAPR’s Stratospheric Rally</h2>Wednesday, before the market opened, Capricor reported positive topline results from the Phase 3 study, dubbed HOPE-3, evaluating its Duchenne Muscular Dystrophy (DMD) cell therapy candidate, Deramiocel.-The primary endpoint, measured as the performance of upper limb (PUL), was met — showing statistically and clinically meaningful treatment effects in 54% of the patients.-The key secondary endpoint of “Left Ventricular Ejection Fraction (LVEF),” a measure of heart health, was also met.&nbsp;Thus, Deramiocel was shown to produce significant skeletal and cardiac benefits, supporting its credentials as a potential “first-in-class therapy” for Duchenne cardiomyopathy, the leading cause of mortality in DMD. The trial also gave the cell therapy a clean chit for its safety and tolerability.Capricor said it would submit the detailed results from the HOPE-3 study at a future scientific meeting and for publication in a peer-reviewed journal.Earlier in July, the FDA shot down Capricor’s initial application for Deramiocel, issuing a complete response letter (CRL) — a notice that an application cannot be approved in its current form. The agency expressed wariness about the company's efficacy data at the time and sought additional data. Industry experts saw it as a signal that the new leadership at the FDA could be veering toward a cautious approach.&nbsp;&nbsp;CEO Linda Marbán said the study results, in addition to the evidence from the HOPE-2 and HOPE-2 OLE studies, would address the clinical issues in the CRL and support regulatory approval.DMD is caused by a mutation in the DMD gene that prevents the body from producing the protein dystrophin. A lack of dystrophin hits muscle fibres, leading to muscle damage and loss.&nbsp;<h2 class="st-heading-2">What’s At Stake For Capricor</h2>According to Grand View Research, the DMD drugs<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.grandviewresearch.com/industry-analysis/duchenne-muscular-dystrophy-dmd-drugs-market">&nbsp;market</a> is expected to grow at a compounded annual growth rate (CAGR) of 16.8% from 2024, reaching $9.91 billion in 2030. North America’s revenue share was at 45% in 2023. Global Data, meanwhile, has a more muted forecast, predicting a $5.2 billion market opportunity in 2033.&nbsp;<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_3_25_08_AM_png_f4173223fa.webp" alt="Screenshot 2025-12-04 at 3.25.08 AM.png">Source: Grandview ResearchThe DMD market is currently led by Sarepta, which has a gene-replacement therapy called Eteplirsen. Elevidys, a one-time single-dose gene transfer therapy, was approved in June 2023, and its label was expanded a year later to include patients ages four and older. The gene therapy generated $131.5 million in revenue for Sarepta in the third quarter.Capricor’s Deramiocel differs from Elevidys in that it is a cell therapy that administers the patient's cardiosphere-derived cells, which secrete exosomes. The latter uses a manufactured gene for delivering the micro-dysrophin gene.Sarepta also has three FDA-approved exon-skipping therapies, Exondys 51, Amondys 45 and Vyondys 53, and it is also currently working on RNA therapies.<h2 class="st-heading-2">Big Price Target Bumps</h2>Following the data, H.C. Wainwright upped the price target for Capricor's stock to $60 from $24 and kept a 'Buy' rating, the Fly reported. The firm called the data a "decisive" win. With 78% of participants having underlying cardiomyopathy, the trial results addressed FDA concerns about sample size, the firm said. It conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.Alliance Global called the data "unequivocally and wholly positive" and removed the speculative tag from the stock. The firm hiked its price target for the stock to $48 from $16.<h2 class="st-heading-2">Retail Convinced Of Capricor Opportunity</h2>On Stocktwits, retail investors held an 'extremely bullish' stance on Capricor stock as of early Thursday. The message volume on the stream was 'extremely high as well.A majority of retail traders are sold on Capricor's long-term potential. An ongoing Stocktwits poll asking users "What's your move on $CAPR after this Phase 3 win?" found that 53% of respondents said "This is legit — CAPR becomes a long-term winner," while 18% remained on the sidelines, waiting for approval to come through. About 29% shrugged off the rally as an "overreaction."<a href="https://stocktwits.com/StocktwitsPolls/message/638043423"><img src="https://news.stocktwits-cdn.com/CAPR_Stocktwits_poll_png_bc7624531b.webp" alt="CAPR Stocktwits poll.png"></a>CAPR stock has&nbsp;soared about 117% this year, as Wednesday's bumper rally helped it recoup all its losses to that point and turn green for the year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/core-weave-vs-nebius-ai-infra-s-breakout-duo-backed-by-nvidia-is-outrunning-big-tech/cLIXYiKRE12">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/whispers-of-an-apple-deal-rebooted-intel-s-year/cLIXAvERE1L">Whispers Of An Apple Deal Rebooted Intel’s Year — Now The Market’s Asking Whether The Old Chip Giant Can Rise Again</a>

In this photo illustration, the lCapricor Therapeutics logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire

 DMD patients may soon gain access to a therapy that not only targets muscle decline but also tackles heart complications — the leading cause of death in this rare genetic disorder.

ETFs to Benefit From Rate Cut Bets and Upbeat Forecasts

ETFs to watch as Wall Street turns upbeat, with bullish forecasts putting the S&P 500 on track for 8,000 by 2026.

IWM
iShares Russell 2000 ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWM News

IWMiShares Russell 2000 ETF